TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/06/2026
Back to search
Official data from USPTO
CONTERA PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
05/08/2026
Trademark type
Combined
Nice classes
5, 35
Filing date
06/19/2023
Registration date
11/05/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/05/2024
Last transaction
05/08/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
24
Owner location
DK
Examiner
HUDSON, TAMARA BREE
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the wording "CONTERA PHARMA" in stylized blue font above a series of vertical blue lines positioned to form a horizontal rectangular shape.
Holders and representatives
Holders
Contera Pharma A/S
C. A. (pessoa física)
Representatives
Julie A. Greenberg Reising Ethington P.C.
Technical classification
Nice Classes
Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Antibiotics; antiviralschemical preparations for pharmaceutical purposesfor treatmentprevention or alleviation of diseases of the central nervous systemneurological disorderspsychiatric disordersmovement disordersextrapyramidal disordershyperkinetic movement disordershypokinetic movement disordersparkinsonismParkinson's Diseasedyskinesias and complications arising from same; drugs for medical purposespharmaceutical preparations for the treatmentprevention or alleviation of diseases of the central nervous systemneurological disorderspsychiatric disordersmovement disordersextrapyramidal disordershyperkinetic movement disordershypokinetic movement disordersparkinsonismParkinson's Diseasedyskinesias and complications arising from same; medicines for human purposes for treatmentprevention or alleviation of diseases of the central nervous systemneurological disorderspsychiatric disordersmovement disordersextrapyramidal disordershyperkinetic movement disordershypokinetic movement disordersparkinsonismParkinson's Diseasedyskinesias and complications arising from same; pharmaceutical preparations for the treatmentprevention or alleviation of diseases of the central nervous systemneurological disorderspsychiatric disordersmovement disordersextrapyramidal disordershyperkinetic movement disordershypokinetic movement disordersparkinsonismParkinson's Diseasedyskinesias and complications arising from same; vitamin preparations; health supplements for medical usehealth food supplementsdietary and nutritional supplementsherbal supplements
Class 35
Pharmaceutical sales promotion for others; business information on pharmaceuticals; business management assistance on pharmaceuticals; analysis of market search data; market research studies; advertising services; arranging of pharmaceutical saleprocuring of contracts for others for the purchase and sale of pharmaceuticals; export-import agency services; sales agency business of health supplementary foodmarketing services for health supplementary foodspromotional marketing and representation services for sales to the public sector of health supplementary foodindependent sales representatives in the field of health supplementary food; retail store services in the field of cosmetics; retail store services in the field of dentifrices; retail store services in the field of toothbrushes
Publications
History of USPTO decisions and trademark events.
31 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/06/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/06/2026
RNWL
INTERNATIONAL REGISTRATION RENEWED
10/02/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/22/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/26/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/08/2025
FIMP
FINAL DISPOSITION PROCESSED
04/08/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/05/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/10/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/22/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/19/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
11/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/20/2024
PUBO
PUBLISHED FOR OPPOSITION
08/20/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/31/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/15/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/10/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/09/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/09/2024
RFNT
REFUSAL PROCESSED BY IB
04/29/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/29/2024
RFRR
REFUSAL PROCESSED BY MPU
03/29/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/08/2024
CNRT
NON-FINAL ACTION WRITTEN
03/07/2024
DOCK
ASSIGNED TO EXAMINER
03/07/2024
MAFR
APPLICATION FILING RECEIPT MAILED
08/11/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/07/2023
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
08/04/2023
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
07/21/2023
Continuous trademark protection
Get notified about every new filing that threatens CONTERA PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.